🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In our prior study on the therapeutic mechanism of UCB, changes in cytokine...
Status
Completed
Location
CHA Bundang Medical Center
Start Date
2015-07-29
Trial ID
NCT03130816
Treatments Being Tested
This is a treatment guideline to allow routine clinical data to be collecte...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2013-01
Trial ID
NCT01685411
Neuroblastoma is a malignant tumor of the sympathetic nervous system. It is...
Status
Terminated
Location
Columbia Presbyterian Medical Center, Morgan Stanley Children's Hospital New York Presbyterian
Start Date
2003-11
Trial ID
NCT00670410
Treatments Being Tested
The purpose of this study is to determine the safety and effectiveness of U...
Status
Completed
Location
Texas Children's Hospital
Start Date
2009-09
Trial ID
NCT00950846
Treatments Being Tested
To observe the effect of stem cell infusion on the development of acute gra...
Status
Recruiting
Location
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital
Start Date
2025-07-11
Trial ID
NCT07047456
Treatments Being Tested
RATIONALE: Giving chemotherapy drugs, such as fludarabine and cyclophospham...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2005-07-28
Trial ID
NCT00309842
Study evaluates the safety and primary efficiency of systemic (i.v.) alloge...
Status
Completed
Location
N.V. Sklifosovsky Emergency Care Institute
Start Date
2013-03-18
Trial ID
NCT04331405
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as alemtuzumab, can block cancer gro...
Status
Completed
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2005-01
Trial ID
NCT00301834
This phase II clinical trial studies how well personalized natural killer (...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2016-05-19
Trial ID
NCT02727803
This is a phase 1, randomized, placebo-controlled, double-blind, single-dos...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12-01
Trial ID
NCT03828344
Treatments Being Tested